Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
OPERATING ACTIVITIES:
Net income (loss)	$ (544,114)	$ 68,670
Adjustment to reconcile net loss to net cash provided by operating activities:
Gain from forgiveness of debt and interest		(449,294)
Derivative liability loss (gain)	74,988	(478,047)
Loss on issuance of notes payable		217,393
Depreciation	3,894	3,895
Amortization of debt discounts	49,863	381,013
Changes in operating assets and liabilities:
Inventory		(12,402)
Accounts receivable		(30,000)
Accrued Interest receivable	(13,137)	(6,277)
Prepaid director’s compensation		12,000
Prepaid management services		(33,333)
Loans receivable	847
Receivable, other		(14,598)
Accounts payable	37,131	(123)
Accrued interest	22,573	60,227
Accrued director’s compensation	38,074
Net cash (used in) operating activities	(329,881)	(280,876)
INVESTING ACTIVITIES:
Notes receivable-long-term		(250,000)
Net cash (used in) investing activities		(250,000)
FINANCING ACTIVITIES:
Issuance of stock for Regulation A financing		915,200
Repayments under loans payable-related parties		(8,927)
Repayments under notes payable		(26,597)
Borrowings from loans payable-officer	5,387
Borrowings from notes payable		223,750
Net cash provided by financing activities	5,387	1,103,426
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(324,494)	572,550
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	324,494	56,300
CASH AND CASH EQUIVALENTS, END OF PERIOD		628,850
Supplemental Disclosures of Cash Flow Information:
Taxes paid
Interest paid
Non-cash investing and financing activities:
Cancellation of common stock and stock to be issued		212,803
Cancellation of common stock as per court order		299,100
Issuance of common stock for debt and accrued interest	$ 251,098	$ 370,819